May the Drug Transporter P Glycoprotein Affect the Antiviral Activity of Human Immunodeficiency Virus Type 1 Proteinase Inhibitors?

This publication has 13 references indexed in Scilit:

• MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
  Nature Medicine, 1999
• Effects of Retroviral-Mediated MDR1 Expression on Hematopoietic Stem Cell Self-Renewal and Differentiation in Culturea
  Annals of the New York Academy of Sciences, 1999
• Human Immunodeficiency Virus Protease Inhibitors Serve as Substrates for Multidrug Transporter Proteins MDR1 and MRP1 but Retain Antiviral Efficacy in Cell Lines Expressing These Transporters
  Antimicrobial Agents and Chemotherapy, 1998
• Interaction of Anti-HIV Protease Inhibitors With the Multidrug Transporter P-Glycoprotein (P-gp) in Human Cultured Cells
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
• HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug Transporter
  Biochemistry, 1998
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
  Journal of Clinical Investigation, 1998
• Multidrug Resistance Associated with Overexpression of MRP
  Published by Springer Nature ,1996
• Zidovudine Induces the Expression of Cellular Resistance Affecting Its Antiviral Activity
  AIDS Research and Human Retroviruses, 1994
• Resistance of HIV-1 to AZT Might Also Involve the Cellular Expression of Multidrug Resistance P-Glycoprotein
  AIDS Research and Human Retroviruses, 1992
• Human immunodeficiency virus I-induced expression of P-glycoprotein
  Biochemical and Biophysical Research Communications, 1990